Journal Watch · PLOS Biology · 2026

USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING.

These data provide new insights and potential therapeutic targets to control viral infections.

Quan J, Zhao X, Chen S et al.PLOS Biology3 min readPharma relevance 60/100

DOI: 10.1371/journal.pbio.3003796PMID: 42113893Study type: preclinical (animal / model) study

TL;DR

These data provide new insights and potential therapeutic targets to control viral infections.

Key findings

  • In addition, we also revealed that USP39 interacts with and stabilizes STING protein by deubiquitinating K48-linked polyubiquitin of STING at K288.
  • These data show that USP39 positively regulates RNA and DNA-virus-induced RIG-I and cGAS-STING signaling, respectively, by promoting post-transcriptional control of RIG-I and stabilization of STING.
  • These data provide new insights and potential therapeutic targets to control viral infections.

What they did

Moreover, USP39-deficient mice were more sensitive to VSV or HSV-1 infection than control mice. Conversely, USP39 overexpression promoted the antiviral immune response. Mechanistically, we found that USP39 regulates RIG-I protein expression by promoting pre-RIG-I mRNA splicing and maturation.

Full abstract (original)

Background: RIG-I and STING are critical for mediating the RIG-I and cGAS-STING signaling pathways that guard against viral infection. Here, we report that ubiquitin-specific peptidase 39 (USP39) positively regulates the RIG-I and cGAS-STING pathways to induce antiviral innate immunity in vitro and in vivo. The USP39 deficiency impaired the antiviral immune response of macrophages, leading to low type I IFNs expression, and high RNA and (e.g., VSV, H1N1 PR8) DNA virus (e.g., HSV-1) replication.

What they did: Moreover, USP39-deficient mice were more sensitive to VSV or HSV-1 infection than control mice. Conversely, USP39 overexpression promoted the antiviral immune response. Mechanistically, we found that USP39 regulates RIG-I protein expression by promoting pre-RIG-I mRNA splicing and maturation.

Results & conclusions: In addition, we also revealed that USP39 interacts with and stabilizes STING protein by deubiquitinating K48-linked polyubiquitin of STING at K288. These data show that USP39 positively regulates RNA and DNA-virus-induced RIG-I and cGAS-STING signaling, respectively, by promoting post-transcriptional control of RIG-I and stabilization of STING. These data provide new insights and potential therapeutic targets to control viral infections.

Abstract © the authors / PLOS Biology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1371/journal.pbio.3003796 · PubMed 42113893.

Why it matters for pharma & biotech

  • Directly relevant to teams in mRNA / delivery technology — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: mRNA / delivery technology

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this PLOS Biology study find?

These data provide new insights and potential therapeutic targets to control viral infections.

What type of study is this?

It is a preclinical (animal / model) study, published in PLOS Biology in 2026. Moreover, USP39-deficient mice were more sensitive to VSV or HSV-1 infection than control mice.

Where can I read the original paper?

The original is at the publisher via DOI 10.1371/journal.pbio.3003796. PubMed ID: 42113893. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Quan J, Zhao X, Chen S et al.. USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING.. PLOS Biology (2026). DOI: 10.1371/journal.pbio.3003796.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/usp39-promotes-antiviral-defense-through-post-transcriptional-control-of-003796/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides